Close

Form 4 MERIT MEDICAL SYSTEMS For: Aug 15 Filed by: Wright Joseph

August 17, 2022 3:48 PM EDT
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Wright Joseph
(Last) (First) (Middle)
1600 WEST MERIT PARKWAY
(Street)
SOUTH JORDAN UT 84095
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
PRESIDENT, INTERNATIONAL
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2022
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, No Par Value 08/15/2022   M   5,000 A $ 16.05 22,031 D  
Common Stock, No Par Value 08/15/2022   S   5,000 D $ 63.25 17,031 D  
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified stock options (right to buy) $ 16.05 08/15/2022   M     5,000 01/28/2017 (1) 01/28/2023 Common Stock 5,000 $ 0 15,000 D  
Non-qualified stock options (right to buy) $ 56.25             03/19/2022 (2) 03/19/2028 Common Stock 9,681   9,681 D  
Non-qualified stock options (right to buy) $ 28.2             04/14/2018 (3) 04/14/2024 Common Stock 25,000   25,000 D  
Non-qualified stock options (right to buy) $ 44.8             03/02/2019 (4) 03/02/2025 Common Stock 25,000   25,000 D  
Non-qualified stock options (right to buy) $ 55.73             03/01/2020 (5) 03/01/2026 Common Stock 30,000   30,000 D  
Non-qualified stock options (right to buy) $ 37.71             02/26/2021 (6) 02/26/2027 Common Stock 16,722   16,722 D  
Non-qualified stock options (right to buy) $ 65.03             02/28/2023 (7) 02/28/2029 Common Stock 8,094   8,094 D  
Explanation of Responses:
1. Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
2. Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
3. Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
4. Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
5. Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
6. Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
7. Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
/s/ Brian G. Lloyd, Attorney-in-Fact 08/17/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. TSLA
5. SPY
6. INFY
7. SNV
8. SMCI
9. SLB
10. JWN



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings